1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > France Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

France Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Summary

GlobalData’s new report, "France Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020", provides key market data on the France Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures. The report provides procedure volumes within market segments - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

France Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Segmentation 4
2.3 Definitions of Procedures Covered in the Report 4
3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France 6
3.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, 2005-2013 6
3.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, 2013-2020 8
3.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, 2005-2013 10
3.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, 2013-2020 12
3.5 ERCP Metal Biliary Stenting Procedures, France, 2005-2013 14
3.6 ERCP Metal Biliary Stenting Procedures, France, 2013-2020 16
4 Appendix 18
4.1 Research Methodology 19
4.1.1 Coverage 19
4.1.2 Secondary Research 19
4.1.3 Primary Research 20
4.1.4 Market Modeling and Forecasting 21
4.1.5 Company Share Analysis 24
4.1.6 Distribution Share Analysis 25
4.2 Expert Panel 25
4.3 GlobalData Consulting 26
4.4 Contact Us 26
4.5 Disclaimer 26

1.1 List of Tables
Table 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Historic, 2005-2013 7
Table 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Forecast, 2013-2020 9
Table 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Historic, 2005-2013 11
Table 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Forecast, 2013-2020 13
Table 5: ERCP Metal Biliary Stenting Procedures, France, Historic, 2005-2013 15
Table 6: ERCP Metal Biliary Stenting Procedures, France, Forecast, 2013-2020 17
Table 7: Total Number of Primary Research Participants, General Surgery Market, by Country 21

1.2 List of Figures
Figure 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Historic, 2005-2013 6
Figure 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Forecast, 2013-2020 8
Figure 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Historic, 2005-2013 10
Figure 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Forecast, 2013-2020 12
Figure 5: ERCP Metal Biliary Stenting Procedures, France, Historic, 2005-2013 14
Figure 6: ERCP Metal Biliary Stenting Procedures, France, Forecast, 2013-2020 16
Figure 7: GlobalData Epidemiology-Based Forecasting Model 23
Figure 8: GlobalData Capital Equipment-Based Forecasting Model 24
Figure 9: Primary Interviews by Participant Type (%) 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.